Search
Now showing items 1-10 of 16
The long and short non-coding RNAs modulating EZH2 signaling in cancer
(2022)
Non-coding RNAs (ncRNAs) are a large family of RNA molecules with no capability in encoding proteins. However, they participate in developmental and biological processes and their abnormal expression affects cancer ...
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
(2022)
Prostate cancer is a leading cause of death worldwide and new estimates revealed prostate cancer as the leading cause of death in men in 2021. Therefore, new strategies are pertinent in the treatment of this malignant ...
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
(2022)
Introduction: The application of doxorubicin (DOX) in cancer therapy has been limited due to its drug resistance and poor internalization. Graphene oxide (GO) nanostructures have the capacity for DOX delivery while promoting ...
Long non-coding RNAs and exosomal incRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
(Elsevier Science, 2022)
Among the different kinds of tumors threatening human life, lung cancer is one that is commonly observed in
both males and females. The aggressive behavior of lung cancer and interactions occurring in tumor microenvironment ...
Non-coding RNAs and macrophage interaction in tumor progression
(Elsevier Ireland Ltd, 2022)
The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage polarization in TME to affect cancer progression. ...
Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer (Journal of Hematology & Oncology, (2022), 15, 1, (18), 10.1186/s13045-022-01235-1)
(BioMed Central Ltd, 2022)
The original article [1] contained an error in co-author, Farid Hashemi’s name which has since been corrected. © 2022, The Author(s).
(Nano)platforms in bladder cancer therapy: Challenges and opportunities
(John Wiley and Sons Inc, 2022)
Urological cancers are among the most common malignancies around the world. In particular, bladder cancer severely threatens human health due to its aggressive and heterogeneous nature. Various therapeutic modalities have ...
Molecular landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention
(PMC, 2022)
Background: One of the most malignant tumors in men is prostate cancer that is still incurable due to its heterog‑
enous and progressive natures. Genetic and epigenetic changes play signifcant roles in its development. ...
Exosomes as promising nanostructures in diabetes mellitus: from insulin sensitivity to ameliorating diabetic complications
(2022)
Diabetes mellitus (DM) is among the chronic metabolic disorders that its incidence rate has shown an increase in developed and wealthy countries due to lifestyle and obesity. The treatment of DM has always been of interest, ...
Nanotechnological approaches in prostate cancer therapy: Integration of engineering and biology
(Elsevier B.V., 2022)
Nanocarriers have received special attention in biomedicine for the treatment of various diseases, especially cancer, as one of the leading causes of death worldwide. Nanocarriers can improve the potential of contemporary ...
